Ramkumar et al. applied several approaches based on CRISPRi and CRISPRa screens to identify pathways of B-cell maturation antigen expression and identify mechanisms of myeloma to BCMA-targeted CAR-T-cell response [209]. The gene discussed is TNFRSF17; the disease is plasma cell myeloma.